SCHEMBL8402170

SCHEMBL8402170

CC(C)(C)OC(=O)N1CCC=C(c2nnn[nH]2)C1

nearest known ligand 0.41

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
MAPK1 P28482 1/20 0.40
NR1H2 P55055 3/20 0.39
ESR2 Q92731 1/20 0.38
DGAT2 Q96PD7 1/20 0.37
HTT P42858 1/20 0.36
ATM Q13315 1/20 0.36
GRM1 Q13255 3/20 0.36
GRM5 P41594 2/20 0.36
PDK4 Q16654 1/20 0.35
USP2 O75604 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
MAPT P10636 2/20 0.35
KDM4E B2RXH2 1/20 0.35
THRB P10828 1/20 0.35
ALDH1A1 P00352 1/20 0.35
LMNA P02545 1/20 0.35
GPR119 Q8TDV5 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8404088 0.78 NR1H2 (0.37) MAPK1NR1H2ESR2MAPTKDM4E
SCHEMBL8404076 0.76 GPR119 (0.34) MAPK1NR1H2HTTGRM1GRM5
SCHEMBL7473234 0.75 GPR119 (0.48) MAPK1NR1H2ESR2DGAT2GRM1
SCHEMBL23124004 0.75 MAPK1 (0.40) MAPK1NR1H2ESR2DGAT2HTT
SCHEMBL30269953 0.74 GPR119 (0.47) MAPK1NR1H2ESR2DGAT2MAPT
SCHEMBL22441484 0.74 GRM1 (0.48) MAPK1NR1H2ESR2DGAT2GRM1
SCHEMBL27157321 0.74 MAPK1 (0.39) MAPK1NR1H2ESR2DGAT2HTT
SCHEMBL6352947 0.74 MAPK1 (0.49) MAPK1NR1H2ESR2GRM1GRM5
SCHEMBL20281789 0.73 ESR2 (0.41) MAPK1NR1H2ESR2DGAT2GRM5
SCHEMBL21425261 0.73 ESR2 (0.43) MAPK1NR1H2ESR2DGAT2GRM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-RE36374-E 1,2,3-triazole and tetrazole substituted piperidine or tetrahydropyridine compounds useful as acetylcholine agonists H. LUNDBECK, A/S (DK) 1999-11-02 US disclosed
EP-0296721-B1 HETEROCYCLIC COMPOUNDS H. LUNDBECK A/S (DK) 1993-06-23 EP disclosed
US-4925858-A NERVOUS SYSTEM DISORDERS, ALZHEIMER*S DISEASE H. LUNDBECK A/S (DK) 1990-05-15 US disclosed
US-4866077-A TREATMENT OF NERVOUS SYSTEM DISORDERS SUCH AS ALZHEIMER*S DISEASE H. LUNDBECK A/S (DK) 1989-09-12 US disclosed
EP-0296721-A2 Heterocyclic compounds H. LUNDBECK A/S (DK) 1988-12-28 EP disclosed